Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-022406
Filing Date
2014-04-14
Accepted
2014-04-14 15:06:26
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v374410_10k.htm 10-K 554743
2 EXHIBIT 31.1 v374410_ex31-1.htm EX-31.1 12404
3 EXHIBIT 31.2 v374410_ex31-2.htm EX-31.2 12090
4 EXHIBIT 32 v374410_ex32.htm EX-32 4120
  Complete submission text file 0001144204-14-022406.txt   4083561

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20131231.xml EX-101.INS 519417
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20131231.xsd EX-101.SCH 49050
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20131231_cal.xml EX-101.CAL 33456
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20131231_def.xml EX-101.DEF 203630
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20131231_lab.xml EX-101.LAB 294986
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20131231_pre.xml EX-101.PRE 250691
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 14762393
SIC: 2834 Pharmaceutical Preparations